Skip to main content
Log in

Preferences for Human Papillomavirus Testing with Routine Cervical Cancer Screening in Diverse Older Women

  • Original Article
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Background

Human papillomavirus (HPV) testing is increasingly being used to determine the optimal cervical cancer screening interval in older women. Little is known about women’s attitudes toward HPV testing or how these attitudes may influence medical discussions about cervical cancer screening.

Methods

Preferences for HPV and concomitant Papanicolaou (Pap) testing were assessed through in-person interviews with diverse women aged 50 to 80 years recruited from community and university-based practices.

Results

Eight hundred and sixty-five women (257 White, 87 African American, 149 Latina, and 372 Asian) were interviewed. Approximately 60% of participants wanted to be tested for HPV and another 15% would undergo testing if recommended by their physician. Among those wanting HPV testing, 94% would want more frequent than annual Pap tests if they had a positive HPV test and a normal Pap test. Two thirds of those under age 65 would be willing to switch to triennial Pap testing, and half of those aged 65 and older would be willing to discontinue Pap testing, if they had a negative HPV test and normal Pap test. Preferences for testing varied by ethnicity, age, place of birth, and cancer history.

Conclusions

The majority of older women were willing to use HPV testing to make decisions about frequency and duration of cervical cancer screening, but up to one third would want at least annual, ongoing screening regardless of HPV test results. Efforts should be made to ensure that HPV testing is used to reinforce appropriate utilization of screening tests.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813–9.

    Article  PubMed  CAS  Google Scholar 

  2. Dunne EF, Markowitz LE. Genital human papillomavirus infection. Clin Infect Dis. 2006;43(5):624–9.

    Article  PubMed  Google Scholar 

  3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65.

    PubMed  CAS  Google Scholar 

  4. Irwin K, Montano D, Kasprzyk D, Carlin L, Freeman C, Barnes R, et al. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States. Obstet Gynecol. 2006;108(2):397–409.

    PubMed  Google Scholar 

  5. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52(6):342–62.

    PubMed  Google Scholar 

  6. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol. 2003;102(2):417–27.

    Article  Google Scholar 

  7. Wright TC Jr., Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197(4):346–55.

    Article  PubMed  Google Scholar 

  8. Wright TC Jr., Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004;103(2):304–9.

    PubMed  Google Scholar 

  9. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357(16):1579–88.

    Article  PubMed  CAS  Google Scholar 

  10. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007;357(16):1589–97.

    Article  PubMed  CAS  Google Scholar 

  11. Haggerty J, Tudiver F, Brown JB, Herbert C, Ciampi A, Guibert R. Patients’ anxiety and expectations: how they influence family physicians’ decisions to order cancer screening tests. Can Fam Physician. 2005;51:1658–9.

    PubMed  Google Scholar 

  12. Tudiver F, Guibert R, Haggerty J, Ciampi A, Medved W, Brown JB, et al. What influences family physicians’ cancer screening decisions when practice guidelines are unclear or conflicting? J Fam Pract. 2002;51(9):760.

    PubMed  Google Scholar 

  13. Anhang R, Stryker JE, Wright TC Jr., Goldie SJ. News media coverage of human papillomavirus. Cancer. 2004;100(2):308–14.

    Article  PubMed  Google Scholar 

  14. Calloway C, Jorgensen CM, Saraiya M, Tsui J. A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002–June 2005. J Womens Health (Larchmt). 2006;15(7):803–9.

    Article  Google Scholar 

  15. Kim SE, Pérez-Stable EJ, Wong S, Gregorich S, Sawaya GF, Walsh JM, et al. Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med. 2008;168(7):728–34.

    Article  PubMed  Google Scholar 

  16. Sirovich BE, Woloshin S, Schwartz LM. Screening for cervical cancer: will women accept less? Am J Med. 2005;118(2):151–8.

    Article  PubMed  Google Scholar 

  17. Guide to Clinical Preventive Services, Third Edition: Periodic Updates. Rockville, Maryland: Agency for Healthcare Research and Quality; 2004. Report No.: AHRQ Publication No. 04-IP0003 Contract No.: Document Number|.

  18. Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer. 2004;101(5 Suppl):1214–28.

    Article  PubMed  Google Scholar 

  19. Wolf AM, Becker DM. Cancer screening and informed patient discussions. Truth and consequences. Arch Intern Med. 1996;156(10):1069–72.

    Article  PubMed  CAS  Google Scholar 

  20. Sheridan SL, Harris RP, Woolf SH. Shared decision making about screening and chemoprevention. a suggested approach from the U.S. Preventive Services Task Force. Am J Prev Med. 2004;26(1):56–66.

    Article  PubMed  Google Scholar 

  21. Eltoum IA, Roberson J. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS). Cancer. 2007;111(1):34–40.

    Article  PubMed  Google Scholar 

  22. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. Jama. 1994;271(23):1866–9.

    Article  PubMed  CAS  Google Scholar 

  23. Walsh JM. Cervical cancer: developments in screening and evaluation of the abnormal Pap smear. West J Med. 1998;169(5):304–10.

    PubMed  CAS  Google Scholar 

  24. Hoffman-Goetz L, Breen NL, Meissner H. The impact of social class on the use of cancer screening within three racial/ethnic groups in the United States. Ethn Dis. 1998;8(1):43–51.

    PubMed  CAS  Google Scholar 

  25. Franks P, Fiscella K, Meldrum S. Racial disparities in the content of primary care office visits. J Gen Intern Med. 2005;20(7):599–603.

    Article  PubMed  Google Scholar 

  26. De Alba I, Ngo-Metzger Q, Sweningson JM, Hubbell FA. Pap smear use in California: are we closing the racial/ethnic gap? Prev Med. 2005;40(6):747–55.

    Article  PubMed  Google Scholar 

  27. Finney MF, Tumiel-Berhalter LM, Fox C, Jaen CR. Breast and cervical cancer screening for Puerto Ricans, African Americans, and non-Hispanic whites attending inner-city family practice centers. Ethn Dis. 2006;16(4):994–1000.

    PubMed  Google Scholar 

  28. Ganesan K, Teklehaimanot S, Akhtar AJ, Wijegunaratne J, Thadepalli K, Ganesan N. Racial differences in preventive practices of African-American and Hispanic women. J Am Geriatr Soc. 2003;51(4):515–8.

    Article  PubMed  Google Scholar 

  29. Kagawa-Singer M, Pourat N. Asian American and Pacific Islander breast and cervical carcinoma screening rates and healthy people 2000 objectives. Cancer. 2000;89(3):696–705.

    Article  PubMed  CAS  Google Scholar 

  30. Do HH, Taylor VM, Burke N, Yasui Y, Schwartz SM, Jackson JC. Knowledge about cervical cancer risk factors, traditional health beliefs, and Pap testing among Vietnamese American women. J Immigr Minor Health. 2007;9(2):109–14.

    Article  PubMed  Google Scholar 

  31. Moreland S, Engelman K, Greiner KA, Mayo MS. Papanicolaou testing among Native American and Hispanic populations. Ethn Dis. 2006;16(1):223–7.

    PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Agency for Healthcare Research and Quality (5P01 HS10856) for an Excellence Center to Eliminate Ethnic/Racial Disparities (EXCEED) and by grant P30-AG15272 under the Resource Centers for Minority Aging Research program by the National Institute on Aging, the National Institute of Nursing Research, and the National Center on Minority Health and Health Disparities, National Institutes of Health. Dr. Huang’s research efforts are further supported by Grant Number KL2RR024130 from the National Center for Research Resources, a component of the National Institutes of Health Clinical and Translational Science Award for Medical Research.

Conflict of Interest

None disclosed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eliseo J. Pérez-Stable MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, A.J., Pérez-Stable, E.J., Kim, S.E. et al. Preferences for Human Papillomavirus Testing with Routine Cervical Cancer Screening in Diverse Older Women. J GEN INTERN MED 23, 1324–1329 (2008). https://doi.org/10.1007/s11606-008-0633-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-008-0633-x

KEY WORDS

Navigation